CloudCath Announces $12 Million Series A Financing for Technology Enabling Remote, Real-Time Complication Monitoring for At-Home Dialysis
Retrieved on:
Thursday, February 13, 2020
Proceeds from the round will be used to commercialize CloudCaths first product, a system that enables remote, real-time monitoring for patients undergoing at-home peritoneal dialysis, allowing earlier complication intervention.
Key Points:
- Proceeds from the round will be used to commercialize CloudCaths first product, a system that enables remote, real-time monitoring for patients undergoing at-home peritoneal dialysis, allowing earlier complication intervention.
- End-stage renal disease, one of the costliest chronic diseases in the U.S., is devastating to patients.
- Founded in 2017, CloudCath is a digital health medical device company that is dedicated to remote complication monitoring for patients undergoing catheter-based treatments.
- The company is headquartered in San Francisco and backed by leading investors in both healthcare and technology.